What are the chances government could ignore a positive result from phase 3 ARDS trials?To me, based on the success of all stem cell trials from various companies around lung conditions being overwhelmingly positive and based on it being the strength of stem cells in general (as its the first point of call after IV)... The study is a near gurantee of success.
My only concern is as it's a novel therapy and one which has had road blocks due to conflicts of interest with 'traditional' big pharma drugs.
Then this could be a potential risk factor to the often corrupt system.
MSB Trading - 2020, page-7991
-
- There are more pages in this discussion • 15,170 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |